A cloud-based system for scalable, privacy-preserving, and interactive immune repertoire analysis in vaccination and infection
A cloud-based system for scalable, privacy-preserving, and interactive immune repertoire analysis in vaccination and infection
批准号:
9557448
负责人:
Jun Xiao
金额:
$30.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-02-06 至 2020-01-31
关键词:
AddressAgingAlgorithm DesignAlgorithmsAntibodiesAntibody RepertoireArchitectureAutoimmune DiseasesB-LymphocytesBasic ScienceBig DataBiomedical ComputingBiomedical ResearchCatalogingCatalogsClinicalClone CellsCloud ComputingCommunitiesCustomDataData AnalysesData AnalyticsData SecurityData SetData SourcesDevelopmentDiseaseElderlyEnvironmentFoundationsFutureGalaxyGenerationsGoalsGrantHIVHealthHeartHypersensitivityImageryImmuneImmune responseImmunizationImmunoglobulin Somatic HypermutationImmunologistIndividualInfantInfectionInfluenzaInfluenza vaccinationInformaticsIngestionInstitutional PolicyInternetInvestigationKnowledgeLengthMalariaMalignant NeoplasmsMeasuresMethodsModernizationOhioOwnershipPerformancePhasePrivacyPrivatizationProcessReceptor CellReceptors, Antigen, B-CellResearchResearch InfrastructureResearch PersonnelRunningServicesSmall Business Innovation Research GrantSoftware ToolsSolidSystemT-Cell ReceptorT-cell receptor repertoireTechnologyTestingUniversitiesUrsidae FamilyVaccinationVaccinesVariantVisualadaptive immune responseadaptive immunityaustinbasecancer cellcloud basedcohortcomputer infrastructurecomputerized data processingcostdata formatdata integrationdata sharingdeep sequencingdesigndisease diagnosisimmune healthinsightnext generation sequencingoutcome forecastparallel processingprogramsscale upskillssuccesstoolweb servicesyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
We propose to build a cloud-based integrated solution for scalable, customizable, privacy-preserving, and
interactive antibody repertoire analysis. Immune repertoire sequencing (IR-seq) has become a useful tool in both
basic research and clinical settings. As the heart of the adaptive immunity to infection and many vaccines, the
abundance and diversity composition of the B cell receptor (BCR) and its dynamic changes in health and
diseases bear information of how to evaluate immune health, perform disease diagnosis and prognosis, and
measure vaccination effect. However, there is a computational bottleneck for large scale antibody lineage
construction, a lack of decomposable pipeline modules that preserve privacy and ownership, and a missing gap
for interactive linage analysis and visualization. In this Phase I grant, we will (1) break the bottlenecks of pipeline
processing and scale up the core algorithms to handle large sequence data sets; (2) protect private data and
proprietary processing algorithms with modularized pipeline, integrated cloud-local processing, and data
perturbation methods; 3) develop end-to-end web services for pipeline composition and interactive analysis
visualization in a cloud-based deployment solution. Existing commercial efforts are mostly focusing on cancer
related IR-seq analysis aiming to trace the disappearing of cancer cells after therapy, which solely focus on
cataloging sequence species and abundance. This kind of analysis is much simpler and easier, compared to
analyzing IR-seq data in infection and vaccination. Providing insights on host immune responses is a much more
challenging but much needed task. Once the pipeline is built, it can be readily adapted to analyze cancer IR-seq
data. Also, existing algorithms and optimizations that have been developed for other big data analysis can be
further developed and applied to the IR-seq data analysis. We will use a publically available BCR repertoire data
on an influenza vaccination cohort and a TCR repertoire data on an aging cohort to test the feasibility of the
project. The long term goal of this proposal is to build cloud based accessible and customizable services for
experts as well as non-specialists. We aim to provide an integrated solution for the ingestion, processing,
analysis, exploration and visualization, interpretation and sharing of data generated by deep sequencing of full
length antibody and TCR repertoire. The success of this Phase I SBIR will provide a solid foundation for the
product launch of a commercial cloud based solution in Phase II, during which we will continue our investigation
on big data security and privacy to facilitate compliance with institutional policies and design and develop
programmable APIs and tools to facilitate integrations with more third party modules and services.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金